Pinnacle Bancorp’s AstraZeneca AZN Stock Holding History

Pinnacle Bancorp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.4K	Buy	+291	New	+$54.7K	0.01%	447
2026 Q1	–	Sell	-596	Closed	-$110K	–	887
2025 Q4	$110K	Hold	596	–	–	0.03%	314
2025 Q3	$91.5K	Hold	596	–	–	0.03%	341
2025 Q2	$83.3K	Buy	596 +97	+19%	+$13.6K	0.03%	348
2025 Q1	$73.3K	Sell	499 -81	-14%	-$11.7K	0.02%	357
2024 Q4	$75.9K	Sell	580 -17	-3%	-$2.38K	0.02%	350
2024 Q3	$92.9K	Hold	597	–	–	0.02%	307
2024 Q2	$93K	Hold	597	–	–	0.03%	287
2024 Q1	$80.8K	Sell	597 -18	-3%	-$2.38K	0.02%	319
2023 Q4	$82.8K	Hold	615	–	–	0.03%	300
2023 Q3	$83.2K	Hold	615	–	–	0.03%	282
2023 Q2	$88K	Hold	615	–	–	0.03%	276
2023 Q1	$85.3K	Hold	615	–	–	0.03%	276
2022 Q4	$83K	Hold	615	–	–	0.03%	272
2022 Q3	$67K	Sell	615 -6	-1%	-$761	0.03%	281
2022 Q2	$82K	Sell	621 -38	-6%	-$4.99K	0.03%	255
2022 Q1	$87K	Buy	659 +78	+13%	+$9.35K	0.03%	263
2021 Q4	$68K	Buy	581 +81	+16%	+$9.53K	0.02%	307
2021 Q3	$60K	Hold	500	–	–	0.02%	316
2021 Q2	$60K	Hold	500	–	–	0.03%	320
2021 Q1	$50K	Hold	500	–	–	0.02%	342
2020 Q4	$50K	Hold	500	–	–	0.03%	318
2020 Q3	$55K	Hold	500	–	–	0.04%	291
2020 Q2	$53K	Hold	500	–	–	0.04%	286
2020 Q1	$45K	Hold	500	–	–	0.04%	270
2019 Q4	$50K	Hold	500	–	–	0.03%	303
2019 Q3	$45K	Hold	500	–	–	0.03%	322
2019 Q2	$41K	Hold	500	–	–	0.02%	336
2019 Q1	$40K	Hold	500	–	–	0.02%	326
2018 Q4	$38K	Buy	+500	New	+$39K	0.02%	326
2017 Q1	$41K	Buy	+658	New	+$38.3K	0.03%	312

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pinnacle Bancorp's AZN Position: Q2 2026 in Review

Pinnacle Bancorp opened a new position in AstraZeneca (AZN) in Q2 2026: 291 shares worth $54.4K. The stake represents 0.01% of the portfolio and ranks #447 among its holdings. This is a return to the name: Pinnacle Bancorp previously reported a position in AZN as recently as Q4 2025.

Pinnacle Bancorp first reported a position in AZN in Q1 2017 and has held it in 31 quarters since. The position peaked at $110K in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Pinnacle Bancorp held 291 shares of AstraZeneca worth $54.4K as of Q2 2026.
AstraZeneca was a new Pinnacle Bancorp position in Q2 2026.
AstraZeneca made up 0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #447 holding.
Pinnacle Bancorp first reported a position in AstraZeneca in Q1 2017 and has held it in 31 quarters since.
Pinnacle Bancorp's AstraZeneca position peaked at $110K in Q4 2025.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.